Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors

📣 Review Article: Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors 👨‍⚕️👩‍⚕️ Mekonnen N et al Read here 👉 https://t.co/HEsdRcs54r

New research: Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors: Homologous recombination (HR) is a highly conserved DNA… https://t.

RT @Negesse14: I am thrilled to share the publication our review article published in frontiers in oncology, cancer genetics section. https…

I am thrilled to share the publication our review article published in frontiers in oncology, cancer genetics section. https://t.co/HPazE1uKNL